|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 1’944.50 GBX | -0.28% |
|
+1.17% | +6.55% |
| 08:38 | Morning Meeting: Der Warsh-Test | |
| 16.06. | GSK erhält kanadische Zulassung für Exdensur zur Behandlung von schwerem Asthma und Nasenpolypen | MT |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 3.59% | 3.76% | 12.52x | 4.63x | 2.73x | 8.02x | 9.05x | 104 Mrd. | ||
| 0.61% | 0.67% | 32.85x | 19.6x | 11.94x | 24.59x | 25.07x | 1’001 Mrd. | ||
| 2.27% | 2.37% | 25.13x | 6.33x | 5.79x | 15.76x | 17.42x | 566 Mrd. | ||
| 3.09% | 3.25% | 27.6x | -809.84x | 6.65x | 13.6x | 13.96x | 393 Mrd. | ||
| 3.09% | 3.17% | 17.38x | 6.41x | 4.29x | 10.55x | 11.91x | 326 Mrd. | ||
| 2.97% | 3.05% | 20.88x | 6.26x | 5.41x | 13.12x | 14.33x | 276 Mrd. | ||
| 1.87% | 1.98% | 22.34x | 5.2x | 4.67x | 13.24x | 13.92x | 277 Mrd. | ||
| 4.05% | 3.88% | 12.39x | 5.42x | 4.65x | 9.51x | 11.16x | 193 Mrd. | ||
| 2.9% | 3.06% | 22.62x | 16.86x | 6.06x | 10.58x | 13.87x | 188 Mrd. | ||
| 2.55% | 2.61% | -45.59x | 8.64x | 5.5x | 30.32x | 61.19x | 158 Mrd. | ||
| 6.73% | 6.7% | 12.18x | 1.69x | 3.19x | 7.76x | 9.03x | 148 Mrd. | ||
| 4.5% | 4.62% | 10.96x | 4.85x | 3.02x | 8.06x | 8.76x | 114 Mrd. | ||
| -.--% | -.--% | 25.91x | 5.2x | 7.84x | 17.68x | 18.41x | 115 Mrd. | ||
| 5.62% | 5.96% | 11.25x | 1.21x | 2.16x | 6.98x | 7.92x | 105 Mrd. | ||
| 1.82% | 2.08% | 24.25x | 5.51x | 8.26x | 15.62x | 16.34x | 77.16 Mrd. | ||
| 3.98% | 4.07% | 44.67x | 1.11x | 2.62x | 9.67x | 27.41x | 49.43 Mrd. | ||
| 0.58% | 0.64% | 33.66x | 4.55x | 7.44x | 24.81x | 25.64x | 46.35 Mrd. | ||
| 0.61% | 2.05% | 15.3x | 1.25x | 1.47x | 6.98x | 11.62x | 41.05 Mrd. | ||
| 2.39% | 2.65% | 17.4x | 1.74x | 3.2x | 12.06x | 13.53x | 39.63 Mrd. | ||
| -.--% | -.--% | 33.07x | 3.9x | 2.96x | 10.51x | 11.71x | 38.32 Mrd. | ||
| Durchschnitt | 2.66% | 2.83% | 18.84x | -34.97x | 4.99x | 13.47x | 17.11x | 212.81 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 2.38% | 2.48% | 21.56x | -66.09x | 6.71x | 15.95x | 18.34x |
- Börse
- Aktien
- A3DMB5 Aktie
- Sektor GSK plc
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















